⌘K

Home/Filings/4/0001209500-09-000023

4//SEC Filing

Blott Peter J 4

Accession 0001209500-09-000023

CIK 0000930184other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:14 PM ET

Size

8.3 KB

Accession

0001209500-09-000023

Insider Transaction Report

Form 4

Period: 2008-07-28

VALEANT PHARMACEUTICALS INTERNATIONALVRX

EVP & CFO

Transactions

Award
Common Stock
2008-07-28+47,600→ 73,600 total

Footnotes (1)

[F1]The restricted stock units are subject to specified performance criteria tied to total shareholder return or other performance criteria as measured on certain specified dates.

Documents

2 files

Issuer

VALEANT PHARMACEUTICALS INTERNATIONAL

CIK 0000930184

Entity typeother

Related Parties

1

filerCIK 0001394128

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 4:14 PM ET
Size: 8.3 KB

View on SEC.gov